Phuong N. Huynh

Array ( [id] => 4785021 [patent_doc_number] => 20080138350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-12 [patent_title] => 'PROCESS FOR USE OF FLUOROQUINOLONES TO REDUCE OR MODULATE INFLAMMATION DUE TO EYE DISEASE OR OPHTHALMIC SURGERY' [patent_app_type] => utility [patent_app_number] => 11/876435 [patent_app_country] => US [patent_app_date] => 2007-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2388 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20080138350.pdf [firstpage_image] =>[orig_patent_app_number] => 11876435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441320 [patent_doc_number] => 20090092959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Nucleic acid and allergenic polypeptides encoded thereby in cashew nuts' [patent_app_type] => utility [patent_app_number] => 11/906801 [patent_app_country] => US [patent_app_date] => 2007-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7330 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092959.pdf [firstpage_image] =>[orig_patent_app_number] => 11906801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4681819 [patent_doc_number] => 20080248045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'POLYPEPTIDES HAVING A TRIGGERING NK ACTIVITY AND BIOLOGICAL APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 11/861511 [patent_app_country] => US [patent_app_date] => 2007-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8075 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248045.pdf [firstpage_image] =>[orig_patent_app_number] => 11861511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273135 [patent_doc_number] => 08637062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Coated implant' [patent_app_type] => utility [patent_app_number] => 12/442188 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3634 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12442188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5315905 [patent_doc_number] => 20090280503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Method for detecting and treating skin disorders' [patent_app_type] => utility [patent_app_number] => 12/310956 [patent_app_country] => US [patent_app_date] => 2007-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12550 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280503.pdf [firstpage_image] =>[orig_patent_app_number] => 12310956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 211391 [patent_doc_number] => 07622297 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Pharmaceutical use of α antigen or α antigen gene' [patent_app_type] => utility [patent_app_number] => 11/896977 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5406 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622297.pdf [firstpage_image] =>[orig_patent_app_number] => 11896977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733337 [patent_doc_number] => 20080050316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'MOLECULAR IMAGING OF EPITHELIAL CELLS IN LYMPH' [patent_app_type] => utility [patent_app_number] => 11/844038 [patent_app_country] => US [patent_app_date] => 2007-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3497 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050316.pdf [firstpage_image] =>[orig_patent_app_number] => 11844038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354675 [patent_doc_number] => 20090186019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/889981 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 48156 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186019.pdf [firstpage_image] =>[orig_patent_app_number] => 11889981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5311033 [patent_doc_number] => 20090018314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 11/840656 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21996 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018314.pdf [firstpage_image] =>[orig_patent_app_number] => 11840656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778279 [patent_doc_number] => 20080286277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/892010 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 53513 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286277.pdf [firstpage_image] =>[orig_patent_app_number] => 11892010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4778279 [patent_doc_number] => 20080286277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/892010 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 53513 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20080286277.pdf [firstpage_image] =>[orig_patent_app_number] => 11892010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6485545 [patent_doc_number] => 20100092992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'LYSINE ACETYLATION SITES' [patent_app_type] => utility [patent_app_number] => 12/310292 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 37337 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12310292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91247 [patent_doc_number] => 07736655 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-15 [patent_title] => 'Soluble inhibitors of vascular endothelial growth factor and use thereof' [patent_app_type] => utility [patent_app_number] => 11/893633 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 41 [patent_no_of_words] => 17691 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/736/07736655.pdf [firstpage_image] =>[orig_patent_app_number] => 11893633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5323521 [patent_doc_number] => 20090061511 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 11/840665 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21970 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20090061511.pdf [firstpage_image] =>[orig_patent_app_number] => 11840665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4812816 [patent_doc_number] => 20080193447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 11/840666 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21974 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193447.pdf [firstpage_image] =>[orig_patent_app_number] => 11840666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4545685 [patent_doc_number] => 07960142 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Stabilized polypeptide compositions' [patent_app_type] => utility [patent_app_number] => 11/894025 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 97 [patent_figures_cnt] => 126 [patent_no_of_words] => 104338 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960142.pdf [firstpage_image] =>[orig_patent_app_number] => 11894025 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4733406 [patent_doc_number] => 20080050385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY' [patent_app_type] => utility [patent_app_number] => 11/840279 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8775 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050385.pdf [firstpage_image] =>[orig_patent_app_number] => 11840279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453516 [patent_doc_number] => 20090069553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'GAMMA-1 AND GAMMA-3 ANTI-HUMAN CD23 MONOCLONAL ANTIBODIES AND USE THEREOF AS THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 11/840649 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21985 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069553.pdf [firstpage_image] =>[orig_patent_app_number] => 11840649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 169775 [patent_doc_number] => 07662377 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-16 [patent_title] => 'Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/889215 [patent_app_country] => US [patent_app_date] => 2007-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 33 [patent_no_of_words] => 47502 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/662/07662377.pdf [firstpage_image] =>[orig_patent_app_number] => 11889215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281630 [patent_doc_number] => 07553629 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Nucleic acid molecules correlated with the Rhesus weak D phenotype' [patent_app_type] => utility [patent_app_number] => 11/834513 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15588 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 318 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553629.pdf [firstpage_image] =>[orig_patent_app_number] => 11834513 [rel_patent_id] =>[rel_patent_doc_number] =>)